nodes	percent_of_prediction	percent_of_DWPC	metapath
Indomethacin—ABCC6—Dactinomycin—testicular cancer	0.0782	0.101	CbGbCtD
Indomethacin—ABCC11—Methotrexate—testicular cancer	0.0507	0.0655	CbGbCtD
Indomethacin—ABCC6—Vinblastine—testicular cancer	0.049	0.0632	CbGbCtD
Indomethacin—ABCC6—Cisplatin—testicular cancer	0.0449	0.0579	CbGbCtD
Indomethacin—ABCC6—Etoposide—testicular cancer	0.0441	0.0569	CbGbCtD
Indomethacin—SLCO1A2—Chlorambucil—testicular cancer	0.0428	0.0553	CbGbCtD
Indomethacin—AKR1C3—Doxorubicin—testicular cancer	0.04	0.0516	CbGbCtD
Indomethacin—ABCC6—Doxorubicin—testicular cancer	0.0301	0.0388	CbGbCtD
Indomethacin—UGT2B7—Epirubicin—testicular cancer	0.0235	0.0303	CbGbCtD
Indomethacin—ABCC1—Dactinomycin—testicular cancer	0.0231	0.0298	CbGbCtD
Indomethacin—ABCC3—Cisplatin—testicular cancer	0.0216	0.0278	CbGbCtD
Indomethacin—ABCC3—Etoposide—testicular cancer	0.0212	0.0274	CbGbCtD
Indomethacin—PTGS1—Ifosfamide—testicular cancer	0.0168	0.0217	CbGbCtD
Indomethacin—ABCC1—Epirubicin—testicular cancer	0.0167	0.0216	CbGbCtD
Indomethacin—UGT1A1—Etoposide—testicular cancer	0.0158	0.0204	CbGbCtD
Indomethacin—ABCC3—Doxorubicin—testicular cancer	0.0145	0.0187	CbGbCtD
Indomethacin—ABCC1—Vinblastine—testicular cancer	0.0144	0.0186	CbGbCtD
Indomethacin—ABCC3—Methotrexate—testicular cancer	0.014	0.0181	CbGbCtD
Indomethacin—ABCC1—Etoposide—testicular cancer	0.013	0.0168	CbGbCtD
Indomethacin—SLC22A11—Methotrexate—testicular cancer	0.0115	0.0148	CbGbCtD
Indomethacin—ABCC2—Carboplatin—testicular cancer	0.0115	0.0148	CbGbCtD
Indomethacin—SLC22A7—Methotrexate—testicular cancer	0.0109	0.0141	CbGbCtD
Indomethacin—ABCC4—Methotrexate—testicular cancer	0.0107	0.0138	CbGbCtD
Indomethacin—ABCC2—Vinblastine—testicular cancer	0.0107	0.0138	CbGbCtD
Indomethacin—ABCC2—Cisplatin—testicular cancer	0.0098	0.0127	CbGbCtD
Indomethacin—PTGS2—Cisplatin—testicular cancer	0.00969	0.0125	CbGbCtD
Indomethacin—ABCC2—Etoposide—testicular cancer	0.00963	0.0124	CbGbCtD
Indomethacin—PTGS2—Etoposide—testicular cancer	0.00952	0.0123	CbGbCtD
Indomethacin—ABCC1—Doxorubicin—testicular cancer	0.00887	0.0115	CbGbCtD
Indomethacin—ABCC1—Methotrexate—testicular cancer	0.0086	0.0111	CbGbCtD
Indomethacin—CYP2C19—Ifosfamide—testicular cancer	0.00814	0.0105	CbGbCtD
Indomethacin—PTGS1—Etoposide—testicular cancer	0.00804	0.0104	CbGbCtD
Indomethacin—SLCO1A2—Methotrexate—testicular cancer	0.00768	0.00991	CbGbCtD
Indomethacin—SLCO1B1—Methotrexate—testicular cancer	0.00724	0.00935	CbGbCtD
Indomethacin—CYP2C9—Ifosfamide—testicular cancer	0.00677	0.00874	CbGbCtD
Indomethacin—SLC22A8—Methotrexate—testicular cancer	0.00668	0.00863	CbGbCtD
Indomethacin—ABCC2—Doxorubicin—testicular cancer	0.00657	0.00848	CbGbCtD
Indomethacin—ABCC2—Methotrexate—testicular cancer	0.00636	0.00821	CbGbCtD
Indomethacin—ABCB1—Dactinomycin—testicular cancer	0.00556	0.00718	CbGbCtD
Indomethacin—SLC22A6—Methotrexate—testicular cancer	0.00466	0.00601	CbGbCtD
Indomethacin—ALB—Methotrexate—testicular cancer	0.00397	0.00512	CbGbCtD
Indomethacin—ABCB1—Vinblastine—testicular cancer	0.00348	0.0045	CbGbCtD
Indomethacin—CYP2C9—Cisplatin—testicular cancer	0.00329	0.00425	CbGbCtD
Indomethacin—PTGR2—embryo—testicular cancer	0.00321	0.0547	CbGeAlD
Indomethacin—ABCB1—Cisplatin—testicular cancer	0.0032	0.00412	CbGbCtD
Indomethacin—ABCC11—embryo—testicular cancer	0.00318	0.0542	CbGeAlD
Indomethacin—ABCB1—Etoposide—testicular cancer	0.00314	0.00405	CbGbCtD
Indomethacin—PTGR2—seminal vesicle—testicular cancer	0.00302	0.0514	CbGeAlD
Indomethacin—ABCC11—gonad—testicular cancer	0.00216	0.0368	CbGeAlD
Indomethacin—ABCB1—Doxorubicin—testicular cancer	0.00214	0.00276	CbGbCtD
Indomethacin—ABCB1—Methotrexate—testicular cancer	0.00207	0.00268	CbGbCtD
Indomethacin—AKR1C3—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00188	0.0637	CbGpPWpGaD
Indomethacin—GLO1—seminal vesicle—testicular cancer	0.00186	0.0317	CbGeAlD
Indomethacin—PTGR2—female gonad—testicular cancer	0.00177	0.0302	CbGeAlD
Indomethacin—ABCC11—female gonad—testicular cancer	0.00175	0.0299	CbGeAlD
Indomethacin—PLA2G2A—seminal vesicle—testicular cancer	0.00173	0.0295	CbGeAlD
Indomethacin—PPARA—embryo—testicular cancer	0.00172	0.0294	CbGeAlD
Indomethacin—PTGR2—testis—testicular cancer	0.00157	0.0268	CbGeAlD
Indomethacin—SLC10A1—seminal vesicle—testicular cancer	0.00156	0.0265	CbGeAlD
Indomethacin—ABCC11—testis—testicular cancer	0.00156	0.0265	CbGeAlD
Indomethacin—GLO1—gonad—testicular cancer	0.00135	0.0229	CbGeAlD
Indomethacin—AKR1C3—seminal vesicle—testicular cancer	0.00135	0.0229	CbGeAlD
Indomethacin—ABCC6—Podofilox—Etoposide—testicular cancer	0.00116	0.328	CbGdCrCtD
Indomethacin—PTGR2—lymph node—testicular cancer	0.00114	0.0194	CbGeAlD
Indomethacin—SLC10A1—gonad—testicular cancer	0.00113	0.0192	CbGeAlD
Indomethacin—GLO1—female gonad—testicular cancer	0.00109	0.0186	CbGeAlD
Indomethacin—PLA2G2A—female gonad—testicular cancer	0.00102	0.0173	CbGeAlD
Indomethacin—AKR1C3—Podofilox—Etoposide—testicular cancer	0.00101	0.286	CbGdCrCtD
Indomethacin—CXCL8—female gonad—testicular cancer	0.00101	0.0172	CbGeAlD
Indomethacin—GLO1—testis—testicular cancer	0.000971	0.0165	CbGeAlD
Indomethacin—PPARA—female gonad—testicular cancer	0.000951	0.0162	CbGeAlD
Indomethacin—PPARG—embryo—testicular cancer	0.000948	0.0161	CbGeAlD
Indomethacin—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000931	0.0315	CbGpPWpGaD
Indomethacin—CES1—NRF2 pathway—SLC2A6—testicular cancer	0.000909	0.0308	CbGpPWpGaD
Indomethacin—PLA2G2A—testis—testicular cancer	0.000903	0.0154	CbGeAlD
Indomethacin—CXCL8—testis—testicular cancer	0.000894	0.0152	CbGeAlD
Indomethacin—AKR1C3—Vincristine—Vinblastine—testicular cancer	0.000866	0.245	CbGdCrCtD
Indomethacin—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000844	0.0286	CbGpPWpGaD
Indomethacin—PPARA—testis—testicular cancer	0.000843	0.0144	CbGeAlD
Indomethacin—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.000819	0.0277	CbGpPWpGaD
Indomethacin—SLC10A1—testis—testicular cancer	0.000811	0.0138	CbGeAlD
Indomethacin—AKR1C3—female gonad—testicular cancer	0.00079	0.0135	CbGeAlD
Indomethacin—UGT2B7—testis—testicular cancer	0.00076	0.0129	CbGeAlD
Indomethacin—PTGDR2—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000724	0.0245	CbGpPWpGaD
Indomethacin—SLC22A7—testis—testicular cancer	0.000723	0.0123	CbGeAlD
Indomethacin—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.00071	0.024	CbGpPWpGaD
Indomethacin—CES1—female gonad—testicular cancer	0.000706	0.012	CbGeAlD
Indomethacin—GLO1—lymph node—testicular cancer	0.000704	0.012	CbGeAlD
Indomethacin—AKR1C3—testis—testicular cancer	0.000701	0.0119	CbGeAlD
Indomethacin—ABCC1—seminal vesicle—testicular cancer	0.000689	0.0117	CbGeAlD
Indomethacin—AKR1C3—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000679	0.023	CbGpPWpGaD
Indomethacin—PLA2G2A—lymph node—testicular cancer	0.000654	0.0111	CbGeAlD
Indomethacin—ABCC11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000651	0.0221	CbGpPWpGaD
Indomethacin—PTGS2—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—HPGDS—testicular cancer	0.00065	0.022	CbGpPWpGaD
Indomethacin—CXCL8—lymph node—testicular cancer	0.000648	0.011	CbGeAlD
Indomethacin—CES1—testis—testicular cancer	0.000626	0.0107	CbGeAlD
Indomethacin—PPARA—lymph node—testicular cancer	0.000611	0.0104	CbGeAlD
Indomethacin—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000592	0.0201	CbGpPWpGaD
Indomethacin—ABCC3—female gonad—testicular cancer	0.000575	0.00979	CbGeAlD
Indomethacin—ABCC4—Ectoderm Differentiation—TFAP2C—testicular cancer	0.000561	0.019	CbGpPWpGaD
Indomethacin—PTGDR2—GPCR ligand binding—INSL3—testicular cancer	0.000551	0.0187	CbGpPWpGaD
Indomethacin—CXCL8—Syndecan-3-mediated signaling events—FGFR3—testicular cancer	0.000536	0.0182	CbGpPWpGaD
Indomethacin—PPARG—female gonad—testicular cancer	0.000523	0.0089	CbGeAlD
Indomethacin—UGT2B7—NRF2 pathway—SLC2A6—testicular cancer	0.000522	0.0177	CbGpPWpGaD
Indomethacin—ABCC3—NRF2 pathway—SLC2A6—testicular cancer	0.000522	0.0177	CbGpPWpGaD
Indomethacin—ABCC3—testis—testicular cancer	0.00051	0.00869	CbGeAlD
Indomethacin—AKR1C3—lymph node—testicular cancer	0.000508	0.00865	CbGeAlD
Indomethacin—PPARG—Teniposide—Etoposide—testicular cancer	0.000498	0.141	CbGdCrCtD
Indomethacin—ABCC6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000494	0.0167	CbGpPWpGaD
Indomethacin—ABCC4—NRF2 pathway—SLC2A6—testicular cancer	0.000491	0.0166	CbGpPWpGaD
Indomethacin—PTGS2—embryo—testicular cancer	0.000484	0.00825	CbGeAlD
Indomethacin—PTGS1—seminal vesicle—testicular cancer	0.000476	0.0081	CbGeAlD
Indomethacin—ABCC4—female gonad—testicular cancer	0.000475	0.00808	CbGeAlD
Indomethacin—PPARG—testis—testicular cancer	0.000464	0.0079	CbGeAlD
Indomethacin—PTGS2—seminal vesicle—testicular cancer	0.000455	0.00775	CbGeAlD
Indomethacin—CES1—lymph node—testicular cancer	0.000454	0.00772	CbGeAlD
Indomethacin—SLCO1A2—testis—testicular cancer	0.000438	0.00745	CbGeAlD
Indomethacin—ALB—testis—testicular cancer	0.000435	0.00741	CbGeAlD
Indomethacin—UGT1A1—NRF2 pathway—SLC2A6—testicular cancer	0.000424	0.0144	CbGpPWpGaD
Indomethacin—UGT1A9—NRF2 pathway—SLC2A6—testicular cancer	0.000424	0.0144	CbGpPWpGaD
Indomethacin—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000423	0.0143	CbGpPWpGaD
Indomethacin—ABCC4—testis—testicular cancer	0.000421	0.00717	CbGeAlD
Indomethacin—CXCL8—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00042	0.0142	CbGpPWpGaD
Indomethacin—ABCC2—NRF2 pathway—SLC2A6—testicular cancer	0.000414	0.014	CbGpPWpGaD
Indomethacin—ABCC2—testis—testicular cancer	0.000408	0.00694	CbGeAlD
Indomethacin—ABCC1—female gonad—testicular cancer	0.000405	0.00689	CbGeAlD
Indomethacin—CXCL8—Bladder Cancer—FGFR3—testicular cancer	0.000392	0.0133	CbGpPWpGaD
Indomethacin—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000384	0.013	CbGpPWpGaD
Indomethacin—ABCC3—lymph node—testicular cancer	0.00037	0.0063	CbGeAlD
Indomethacin—ABCC1—testis—testicular cancer	0.000359	0.00611	CbGeAlD
Indomethacin—ABCC1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00035	0.0118	CbGpPWpGaD
Indomethacin—CXCL8—Syndecan-2-mediated signaling events—FGFR3—testicular cancer	0.000348	0.0118	CbGpPWpGaD
Indomethacin—PPARG—lymph node—testicular cancer	0.000336	0.00572	CbGeAlD
Indomethacin—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000323	0.0109	CbGpPWpGaD
Indomethacin—PPARA—Developmental Biology—PRDM14—testicular cancer	0.000319	0.0108	CbGpPWpGaD
Indomethacin—ALB—lymph node—testicular cancer	0.000315	0.00537	CbGeAlD
Indomethacin—PTGDR2—GPCR downstream signaling—INSL3—testicular cancer	0.000312	0.0106	CbGpPWpGaD
Indomethacin—ABCC4—lymph node—testicular cancer	0.000305	0.0052	CbGeAlD
Indomethacin—ABCB1—embryo—testicular cancer	0.0003	0.0051	CbGeAlD
Indomethacin—PTGS1—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000296	0.01	CbGpPWpGaD
Indomethacin—ABCC2—lymph node—testicular cancer	0.000295	0.00503	CbGeAlD
Indomethacin—SLCO1A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000286	0.0097	CbGpPWpGaD
Indomethacin—UGT2B7—Phase II conjugation—HPGDS—testicular cancer	0.000284	0.00962	CbGpPWpGaD
Indomethacin—CXCL8—Syndecan-2-mediated signaling events—MMP2—testicular cancer	0.000283	0.0096	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling by GPCR—INSL3—testicular cancer	0.000283	0.00958	CbGpPWpGaD
Indomethacin—CXCL8—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000282	0.00955	CbGpPWpGaD
Indomethacin—ABCB1—seminal vesicle—testicular cancer	0.000281	0.00479	CbGeAlD
Indomethacin—PTGS1—female gonad—testicular cancer	0.00028	0.00476	CbGeAlD
Indomethacin—CXCL8—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—testicular cancer	0.000277	0.00939	CbGpPWpGaD
Indomethacin—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000269	0.00912	CbGpPWpGaD
Indomethacin—PTGS2—female gonad—testicular cancer	0.000267	0.00455	CbGeAlD
Indomethacin—ABCC1—lymph node—testicular cancer	0.00026	0.00443	CbGeAlD
Indomethacin—PTGS2—Aryl Hydrocarbon Receptor—HPGDS—testicular cancer	0.000251	0.0085	CbGpPWpGaD
Indomethacin—PTGS1—testis—testicular cancer	0.000248	0.00422	CbGeAlD
Indomethacin—SLCO1B1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000245	0.00829	CbGpPWpGaD
Indomethacin—PTGS2—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000235	0.00795	CbGpPWpGaD
Indomethacin—UGT1A1—Phase II conjugation—HPGDS—testicular cancer	0.000231	0.00782	CbGpPWpGaD
Indomethacin—UGT1A9—Phase II conjugation—HPGDS—testicular cancer	0.000231	0.00782	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—PRDM14—testicular cancer	0.000228	0.00773	CbGpPWpGaD
Indomethacin—PPARA—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000221	0.00747	CbGpPWpGaD
Indomethacin—CXCL8—Senescence-Associated Secretory Phenotype (SASP)—H2AFZ—testicular cancer	0.000216	0.00733	CbGpPWpGaD
Indomethacin—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000215	0.00728	CbGpPWpGaD
Indomethacin—CXCL8—GPCR ligand binding—INSL3—testicular cancer	0.000215	0.00727	CbGpPWpGaD
Indomethacin—ABCB1—gonad—testicular cancer	0.000203	0.00346	CbGeAlD
Indomethacin—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000195	0.0066	CbGpPWpGaD
Indomethacin—CXCL8—ATF-2 transcription factor network—MMP2—testicular cancer	0.000191	0.00646	CbGpPWpGaD
Indomethacin—PTGS1—lymph node—testicular cancer	0.00018	0.00306	CbGeAlD
Indomethacin—CXCL8—LPA receptor mediated events—MMP2—testicular cancer	0.000179	0.00606	CbGpPWpGaD
Indomethacin—PTGS2—lymph node—testicular cancer	0.000172	0.00292	CbGeAlD
Indomethacin—CYP2C19—Arachidonic acid metabolism—HPGDS—testicular cancer	0.00017	0.00577	CbGpPWpGaD
Indomethacin—ABCC3—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000167	0.00566	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—INSL3—testicular cancer	0.000167	0.00566	CbGpPWpGaD
Indomethacin—UGT2B7—Biological oxidations—HPGDS—testicular cancer	0.000166	0.00563	CbGpPWpGaD
Indomethacin—ABCB1—female gonad—testicular cancer	0.000165	0.00281	CbGeAlD
Indomethacin—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000164	0.00555	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—MAD1L1—testicular cancer	0.000162	0.0055	CbGpPWpGaD
Indomethacin—ABCC4—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000157	0.00532	CbGpPWpGaD
Indomethacin—CYP2C9—Arachidonic acid metabolism—HPGDS—testicular cancer	0.000155	0.00526	CbGpPWpGaD
Indomethacin—CXCL8—Regulation of nuclear beta catenin signaling and target gene transcription—MMP2—testicular cancer	0.00015	0.00507	CbGpPWpGaD
Indomethacin—ABCB1—testis—testicular cancer	0.000147	0.0025	CbGeAlD
Indomethacin—SLCO1A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000146	0.00493	CbGpPWpGaD
Indomethacin—ALB—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00014	0.00474	CbGpPWpGaD
Indomethacin—CXCL8—Cellular Senescence—H2AFZ—testicular cancer	0.000137	0.00464	CbGpPWpGaD
Indomethacin—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000137	0.00463	CbGpPWpGaD
Indomethacin—UGT1A1—Biological oxidations—HPGDS—testicular cancer	0.000135	0.00457	CbGpPWpGaD
Indomethacin—UGT1A9—Biological oxidations—HPGDS—testicular cancer	0.000135	0.00457	CbGpPWpGaD
Indomethacin—PLA2G2A—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000133	0.0045	CbGpPWpGaD
Indomethacin—ABCC2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000132	0.00449	CbGpPWpGaD
Indomethacin—ABCC1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000131	0.00444	CbGpPWpGaD
Indomethacin—SLCO1B1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000124	0.00422	CbGpPWpGaD
Indomethacin—CXCL8—GPCR downstream signaling—INSL3—testicular cancer	0.000121	0.00411	CbGpPWpGaD
Indomethacin—PTGS2—C-MYB transcription factor network—H2AFZ—testicular cancer	0.000113	0.00384	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	0.000113	0.00382	CbGpPWpGaD
Indomethacin—CXCL8—Signaling by GPCR—INSL3—testicular cancer	0.00011	0.00373	CbGpPWpGaD
Indomethacin—PTGS1—Biological oxidations—HPGDS—testicular cancer	0.00011	0.00373	CbGpPWpGaD
Indomethacin—Rash—Bleomycin—testicular cancer	0.00011	0.000822	CcSEcCtD
Indomethacin—Gastritis—Doxorubicin—testicular cancer	0.00011	0.000822	CcSEcCtD
Indomethacin—Pain—Cisplatin—testicular cancer	0.00011	0.000822	CcSEcCtD
Indomethacin—Dermatitis—Bleomycin—testicular cancer	0.00011	0.000821	CcSEcCtD
Indomethacin—Hypersensitivity—Ifosfamide—testicular cancer	0.00011	0.000821	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Methotrexate—testicular cancer	0.000109	0.000819	CcSEcCtD
Indomethacin—Muscular weakness—Doxorubicin—testicular cancer	0.000109	0.000819	CcSEcCtD
Indomethacin—Renal failure—Methotrexate—testicular cancer	0.000108	0.000813	CcSEcCtD
Indomethacin—Abdominal distension—Doxorubicin—testicular cancer	0.000108	0.000808	CcSEcCtD
Indomethacin—Stomatitis—Methotrexate—testicular cancer	0.000108	0.000806	CcSEcCtD
Indomethacin—Asthma—Doxorubicin—testicular cancer	0.000107	0.000803	CcSEcCtD
Indomethacin—Pollakiuria—Epirubicin—testicular cancer	0.000107	0.000801	CcSEcCtD
Indomethacin—Asthenia—Ifosfamide—testicular cancer	0.000107	0.0008	CcSEcCtD
Indomethacin—ABCB1—lymph node—testicular cancer	0.000106	0.00181	CbGeAlD
Indomethacin—Sweating—Methotrexate—testicular cancer	0.000106	0.000792	CcSEcCtD
Indomethacin—Feeling abnormal—Cisplatin—testicular cancer	0.000106	0.000792	CcSEcCtD
Indomethacin—Paraesthesia—Etoposide—testicular cancer	0.000105	0.00079	CcSEcCtD
Indomethacin—Weight increased—Epirubicin—testicular cancer	0.000105	0.00079	CcSEcCtD
Indomethacin—Pruritus—Ifosfamide—testicular cancer	0.000105	0.000788	CcSEcCtD
Indomethacin—Haematuria—Methotrexate—testicular cancer	0.000105	0.000788	CcSEcCtD
Indomethacin—Dyspnoea—Etoposide—testicular cancer	0.000105	0.000785	CcSEcCtD
Indomethacin—Hyperglycaemia—Epirubicin—testicular cancer	0.000104	0.000783	CcSEcCtD
Indomethacin—Somnolence—Etoposide—testicular cancer	0.000104	0.000782	CcSEcCtD
Indomethacin—PTGS2—C-MYB transcription factor network—KITLG—testicular cancer	0.000104	0.00353	CbGpPWpGaD
Indomethacin—Epistaxis—Methotrexate—testicular cancer	0.000104	0.00078	CcSEcCtD
Indomethacin—CXCL8—Cellular responses to stress—H2AFZ—testicular cancer	0.000103	0.0035	CbGpPWpGaD
Indomethacin—Nausea—Bleomycin—testicular cancer	0.000103	0.000774	CcSEcCtD
Indomethacin—Drowsiness—Epirubicin—testicular cancer	0.000103	0.000774	CcSEcCtD
Indomethacin—Vomiting—Dactinomycin—testicular cancer	0.000103	0.000773	CcSEcCtD
Indomethacin—Agranulocytosis—Methotrexate—testicular cancer	0.000103	0.000771	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Epirubicin—testicular cancer	0.000102	0.000767	CcSEcCtD
Indomethacin—Rash—Dactinomycin—testicular cancer	0.000102	0.000767	CcSEcCtD
Indomethacin—Decreased appetite—Etoposide—testicular cancer	0.000102	0.000765	CcSEcCtD
Indomethacin—Diarrhoea—Ifosfamide—testicular cancer	0.000102	0.000762	CcSEcCtD
Indomethacin—Pancytopenia—Doxorubicin—testicular cancer	0.000102	0.000762	CcSEcCtD
Indomethacin—Renal failure—Epirubicin—testicular cancer	0.000101	0.00076	CcSEcCtD
Indomethacin—Body temperature increased—Cisplatin—testicular cancer	0.000101	0.000759	CcSEcCtD
Indomethacin—Fatigue—Etoposide—testicular cancer	0.000101	0.000759	CcSEcCtD
Indomethacin—Neuropathy peripheral—Epirubicin—testicular cancer	0.000101	0.000758	CcSEcCtD
Indomethacin—PPARA—Gene Expression—DNMT3L—testicular cancer	0.000101	0.00341	CbGpPWpGaD
Indomethacin—Jaundice—Epirubicin—testicular cancer	0.000101	0.000754	CcSEcCtD
Indomethacin—Stomatitis—Epirubicin—testicular cancer	0.000101	0.000754	CcSEcCtD
Indomethacin—Pain—Etoposide—testicular cancer	0.0001	0.000753	CcSEcCtD
Indomethacin—Constipation—Etoposide—testicular cancer	0.0001	0.000753	CcSEcCtD
Indomethacin—Haemoglobin—Methotrexate—testicular cancer	9.95e-05	0.000746	CcSEcCtD
Indomethacin—Hepatitis—Methotrexate—testicular cancer	9.9e-05	0.000742	CcSEcCtD
Indomethacin—Haemorrhage—Methotrexate—testicular cancer	9.9e-05	0.000742	CcSEcCtD
Indomethacin—Sweating—Epirubicin—testicular cancer	9.9e-05	0.000742	CcSEcCtD
Indomethacin—Pollakiuria—Doxorubicin—testicular cancer	9.9e-05	0.000742	CcSEcCtD
Indomethacin—Haematuria—Epirubicin—testicular cancer	9.84e-05	0.000738	CcSEcCtD
Indomethacin—Dizziness—Ifosfamide—testicular cancer	9.83e-05	0.000737	CcSEcCtD
Indomethacin—Weight increased—Doxorubicin—testicular cancer	9.75e-05	0.000731	CcSEcCtD
Indomethacin—Epistaxis—Epirubicin—testicular cancer	9.74e-05	0.00073	CcSEcCtD
Indomethacin—AKR1C3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	9.71e-05	0.00329	CbGpPWpGaD
Indomethacin—Feeling abnormal—Etoposide—testicular cancer	9.68e-05	0.000725	CcSEcCtD
Indomethacin—Hyperglycaemia—Doxorubicin—testicular cancer	9.66e-05	0.000724	CcSEcCtD
Indomethacin—Nausea—Dactinomycin—testicular cancer	9.64e-05	0.000722	CcSEcCtD
Indomethacin—Agranulocytosis—Epirubicin—testicular cancer	9.63e-05	0.000722	CcSEcCtD
Indomethacin—Gastrointestinal pain—Etoposide—testicular cancer	9.6e-05	0.00072	CcSEcCtD
Indomethacin—Drowsiness—Doxorubicin—testicular cancer	9.55e-05	0.000716	CcSEcCtD
Indomethacin—Stevens-Johnson syndrome—Doxorubicin—testicular cancer	9.47e-05	0.00071	CcSEcCtD
Indomethacin—Vomiting—Ifosfamide—testicular cancer	9.46e-05	0.000709	CcSEcCtD
Indomethacin—Hypersensitivity—Cisplatin—testicular cancer	9.45e-05	0.000708	CcSEcCtD
Indomethacin—Bradycardia—Epirubicin—testicular cancer	9.43e-05	0.000707	CcSEcCtD
Indomethacin—Renal failure—Doxorubicin—testicular cancer	9.39e-05	0.000704	CcSEcCtD
Indomethacin—Rash—Ifosfamide—testicular cancer	9.38e-05	0.000703	CcSEcCtD
Indomethacin—Dermatitis—Ifosfamide—testicular cancer	9.37e-05	0.000702	CcSEcCtD
Indomethacin—Erythema multiforme—Methotrexate—testicular cancer	9.36e-05	0.000702	CcSEcCtD
Indomethacin—Neuropathy peripheral—Doxorubicin—testicular cancer	9.36e-05	0.000702	CcSEcCtD
Indomethacin—Urticaria—Etoposide—testicular cancer	9.33e-05	0.000699	CcSEcCtD
Indomethacin—Haemoglobin—Epirubicin—testicular cancer	9.31e-05	0.000698	CcSEcCtD
Indomethacin—Stomatitis—Doxorubicin—testicular cancer	9.31e-05	0.000698	CcSEcCtD
Indomethacin—Jaundice—Doxorubicin—testicular cancer	9.31e-05	0.000698	CcSEcCtD
Indomethacin—Abdominal pain—Etoposide—testicular cancer	9.28e-05	0.000696	CcSEcCtD
Indomethacin—Body temperature increased—Etoposide—testicular cancer	9.28e-05	0.000696	CcSEcCtD
Indomethacin—Hepatitis—Epirubicin—testicular cancer	9.27e-05	0.000694	CcSEcCtD
Indomethacin—Haemorrhage—Epirubicin—testicular cancer	9.27e-05	0.000694	CcSEcCtD
Indomethacin—Tinnitus—Methotrexate—testicular cancer	9.23e-05	0.000692	CcSEcCtD
Indomethacin—Asthenia—Cisplatin—testicular cancer	9.2e-05	0.000689	CcSEcCtD
Indomethacin—Sweating—Doxorubicin—testicular cancer	9.16e-05	0.000686	CcSEcCtD
Indomethacin—Haematuria—Doxorubicin—testicular cancer	9.11e-05	0.000682	CcSEcCtD
Indomethacin—Epistaxis—Doxorubicin—testicular cancer	9.01e-05	0.000675	CcSEcCtD
Indomethacin—Agranulocytosis—Doxorubicin—testicular cancer	8.91e-05	0.000668	CcSEcCtD
Indomethacin—Nausea—Ifosfamide—testicular cancer	8.83e-05	0.000662	CcSEcCtD
Indomethacin—Diarrhoea—Cisplatin—testicular cancer	8.77e-05	0.000657	CcSEcCtD
Indomethacin—Erythema multiforme—Epirubicin—testicular cancer	8.76e-05	0.000657	CcSEcCtD
Indomethacin—Alopecia—Methotrexate—testicular cancer	8.75e-05	0.000656	CcSEcCtD
Indomethacin—Bradycardia—Doxorubicin—testicular cancer	8.73e-05	0.000654	CcSEcCtD
Indomethacin—Hypersensitivity—Etoposide—testicular cancer	8.65e-05	0.000648	CcSEcCtD
Indomethacin—Tinnitus—Epirubicin—testicular cancer	8.64e-05	0.000647	CcSEcCtD
Indomethacin—Erythema—Methotrexate—testicular cancer	8.62e-05	0.000646	CcSEcCtD
Indomethacin—Haemoglobin—Doxorubicin—testicular cancer	8.62e-05	0.000646	CcSEcCtD
Indomethacin—Flushing—Epirubicin—testicular cancer	8.6e-05	0.000644	CcSEcCtD
Indomethacin—Haemorrhage—Doxorubicin—testicular cancer	8.57e-05	0.000643	CcSEcCtD
Indomethacin—Hepatitis—Doxorubicin—testicular cancer	8.57e-05	0.000643	CcSEcCtD
Indomethacin—Asthenia—Etoposide—testicular cancer	8.43e-05	0.000631	CcSEcCtD
Indomethacin—PPARA—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	8.42e-05	0.00285	CbGpPWpGaD
Indomethacin—Pruritus—Etoposide—testicular cancer	8.31e-05	0.000623	CcSEcCtD
Indomethacin—Arrhythmia—Epirubicin—testicular cancer	8.28e-05	0.00062	CcSEcCtD
Indomethacin—AKR1C3—Signaling Pathways—INSL3—testicular cancer	8.25e-05	0.0028	CbGpPWpGaD
Indomethacin—Alopecia—Epirubicin—testicular cancer	8.19e-05	0.000614	CcSEcCtD
Indomethacin—Vomiting—Cisplatin—testicular cancer	8.15e-05	0.000611	CcSEcCtD
Indomethacin—Vision blurred—Methotrexate—testicular cancer	8.12e-05	0.000609	CcSEcCtD
Indomethacin—Erythema multiforme—Doxorubicin—testicular cancer	8.11e-05	0.000607	CcSEcCtD
Indomethacin—Rash—Cisplatin—testicular cancer	8.08e-05	0.000606	CcSEcCtD
Indomethacin—Dermatitis—Cisplatin—testicular cancer	8.08e-05	0.000605	CcSEcCtD
Indomethacin—Erythema—Epirubicin—testicular cancer	8.07e-05	0.000604	CcSEcCtD
Indomethacin—Diarrhoea—Etoposide—testicular cancer	8.04e-05	0.000602	CcSEcCtD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	8.03e-05	0.00272	CbGpPWpGaD
Indomethacin—Ill-defined disorder—Methotrexate—testicular cancer	8e-05	0.000599	CcSEcCtD
Indomethacin—Tinnitus—Doxorubicin—testicular cancer	7.99e-05	0.000599	CcSEcCtD
Indomethacin—Anaemia—Methotrexate—testicular cancer	7.97e-05	0.000597	CcSEcCtD
Indomethacin—Flushing—Doxorubicin—testicular cancer	7.96e-05	0.000596	CcSEcCtD
Indomethacin—Flatulence—Epirubicin—testicular cancer	7.95e-05	0.000596	CcSEcCtD
Indomethacin—Tension—Epirubicin—testicular cancer	7.92e-05	0.000593	CcSEcCtD
Indomethacin—Nervousness—Epirubicin—testicular cancer	7.84e-05	0.000587	CcSEcCtD
Indomethacin—Malaise—Methotrexate—testicular cancer	7.77e-05	0.000582	CcSEcCtD
Indomethacin—Dizziness—Etoposide—testicular cancer	7.77e-05	0.000582	CcSEcCtD
Indomethacin—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—testicular cancer	7.76e-05	0.00263	CbGpPWpGaD
Indomethacin—Vertigo—Methotrexate—testicular cancer	7.74e-05	0.00058	CcSEcCtD
Indomethacin—Leukopenia—Methotrexate—testicular cancer	7.72e-05	0.000578	CcSEcCtD
Indomethacin—Arrhythmia—Doxorubicin—testicular cancer	7.66e-05	0.000574	CcSEcCtD
Indomethacin—Nausea—Cisplatin—testicular cancer	7.62e-05	0.000571	CcSEcCtD
Indomethacin—Vision blurred—Epirubicin—testicular cancer	7.6e-05	0.00057	CcSEcCtD
Indomethacin—Alopecia—Doxorubicin—testicular cancer	7.58e-05	0.000568	CcSEcCtD
Indomethacin—Ill-defined disorder—Epirubicin—testicular cancer	7.48e-05	0.000561	CcSEcCtD
Indomethacin—Convulsion—Methotrexate—testicular cancer	7.47e-05	0.00056	CcSEcCtD
Indomethacin—Vomiting—Etoposide—testicular cancer	7.47e-05	0.00056	CcSEcCtD
Indomethacin—Erythema—Doxorubicin—testicular cancer	7.46e-05	0.000559	CcSEcCtD
Indomethacin—Anaemia—Epirubicin—testicular cancer	7.46e-05	0.000559	CcSEcCtD
Indomethacin—Rash—Etoposide—testicular cancer	7.41e-05	0.000555	CcSEcCtD
Indomethacin—Dermatitis—Etoposide—testicular cancer	7.4e-05	0.000554	CcSEcCtD
Indomethacin—Headache—Etoposide—testicular cancer	7.36e-05	0.000551	CcSEcCtD
Indomethacin—Flatulence—Doxorubicin—testicular cancer	7.36e-05	0.000551	CcSEcCtD
Indomethacin—Chest pain—Methotrexate—testicular cancer	7.34e-05	0.00055	CcSEcCtD
Indomethacin—Tension—Doxorubicin—testicular cancer	7.32e-05	0.000549	CcSEcCtD
Indomethacin—Malaise—Epirubicin—testicular cancer	7.27e-05	0.000545	CcSEcCtD
Indomethacin—Discomfort—Methotrexate—testicular cancer	7.25e-05	0.000543	CcSEcCtD
Indomethacin—Nervousness—Doxorubicin—testicular cancer	7.25e-05	0.000543	CcSEcCtD
Indomethacin—Vertigo—Epirubicin—testicular cancer	7.25e-05	0.000543	CcSEcCtD
Indomethacin—Syncope—Epirubicin—testicular cancer	7.23e-05	0.000542	CcSEcCtD
Indomethacin—Leukopenia—Epirubicin—testicular cancer	7.22e-05	0.000541	CcSEcCtD
Indomethacin—PPARG—Gene Expression—DNMT3L—testicular cancer	7.21e-05	0.00244	CbGpPWpGaD
Indomethacin—Palpitations—Epirubicin—testicular cancer	7.13e-05	0.000534	CcSEcCtD
Indomethacin—PTGS2—C-MYB transcription factor network—KIT—testicular cancer	7.11e-05	0.00241	CbGpPWpGaD
Indomethacin—ALB—Transmembrane transport of small molecules—SLC2A6—testicular cancer	7.11e-05	0.00241	CbGpPWpGaD
Indomethacin—Confusional state—Methotrexate—testicular cancer	7.09e-05	0.000532	CcSEcCtD
Indomethacin—Loss of consciousness—Epirubicin—testicular cancer	7.09e-05	0.000531	CcSEcCtD
Indomethacin—Anaphylactic shock—Methotrexate—testicular cancer	7.04e-05	0.000527	CcSEcCtD
Indomethacin—Vision blurred—Doxorubicin—testicular cancer	7.03e-05	0.000527	CcSEcCtD
Indomethacin—Convulsion—Epirubicin—testicular cancer	6.99e-05	0.000524	CcSEcCtD
Indomethacin—Nausea—Etoposide—testicular cancer	6.98e-05	0.000523	CcSEcCtD
Indomethacin—Hypertension—Epirubicin—testicular cancer	6.96e-05	0.000522	CcSEcCtD
Indomethacin—Ill-defined disorder—Doxorubicin—testicular cancer	6.93e-05	0.000519	CcSEcCtD
Indomethacin—Anaemia—Doxorubicin—testicular cancer	6.9e-05	0.000517	CcSEcCtD
Indomethacin—Thrombocytopenia—Methotrexate—testicular cancer	6.89e-05	0.000516	CcSEcCtD
Indomethacin—Chest pain—Epirubicin—testicular cancer	6.87e-05	0.000515	CcSEcCtD
Indomethacin—Anxiety—Epirubicin—testicular cancer	6.84e-05	0.000513	CcSEcCtD
Indomethacin—Hyperhidrosis—Methotrexate—testicular cancer	6.8e-05	0.00051	CcSEcCtD
Indomethacin—Discomfort—Epirubicin—testicular cancer	6.79e-05	0.000508	CcSEcCtD
Indomethacin—Malaise—Doxorubicin—testicular cancer	6.73e-05	0.000504	CcSEcCtD
Indomethacin—Vertigo—Doxorubicin—testicular cancer	6.71e-05	0.000503	CcSEcCtD
Indomethacin—Anorexia—Methotrexate—testicular cancer	6.71e-05	0.000503	CcSEcCtD
Indomethacin—Syncope—Doxorubicin—testicular cancer	6.69e-05	0.000502	CcSEcCtD
Indomethacin—Leukopenia—Doxorubicin—testicular cancer	6.68e-05	0.000501	CcSEcCtD
Indomethacin—Confusional state—Epirubicin—testicular cancer	6.64e-05	0.000497	CcSEcCtD
Indomethacin—Palpitations—Doxorubicin—testicular cancer	6.6e-05	0.000494	CcSEcCtD
Indomethacin—Anaphylactic shock—Epirubicin—testicular cancer	6.58e-05	0.000493	CcSEcCtD
Indomethacin—Oedema—Epirubicin—testicular cancer	6.58e-05	0.000493	CcSEcCtD
Indomethacin—Hypotension—Methotrexate—testicular cancer	6.57e-05	0.000493	CcSEcCtD
Indomethacin—Loss of consciousness—Doxorubicin—testicular cancer	6.56e-05	0.000492	CcSEcCtD
Indomethacin—CXCL8—Signaling Pathways—INSL3—testicular cancer	6.51e-05	0.00221	CbGpPWpGaD
Indomethacin—Shock—Epirubicin—testicular cancer	6.48e-05	0.000485	CcSEcCtD
Indomethacin—Convulsion—Doxorubicin—testicular cancer	6.47e-05	0.000485	CcSEcCtD
Indomethacin—Thrombocytopenia—Epirubicin—testicular cancer	6.45e-05	0.000483	CcSEcCtD
Indomethacin—Hypertension—Doxorubicin—testicular cancer	6.44e-05	0.000483	CcSEcCtD
Indomethacin—Tachycardia—Epirubicin—testicular cancer	6.43e-05	0.000481	CcSEcCtD
Indomethacin—ABCC3—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.38e-05	0.00216	CbGpPWpGaD
Indomethacin—Hyperhidrosis—Epirubicin—testicular cancer	6.36e-05	0.000477	CcSEcCtD
Indomethacin—Insomnia—Methotrexate—testicular cancer	6.36e-05	0.000477	CcSEcCtD
Indomethacin—Chest pain—Doxorubicin—testicular cancer	6.35e-05	0.000476	CcSEcCtD
Indomethacin—CYP2C19—Biological oxidations—HPGDS—testicular cancer	6.34e-05	0.00215	CbGpPWpGaD
Indomethacin—Anxiety—Doxorubicin—testicular cancer	6.33e-05	0.000475	CcSEcCtD
Indomethacin—Paraesthesia—Methotrexate—testicular cancer	6.32e-05	0.000473	CcSEcCtD
Indomethacin—Discomfort—Doxorubicin—testicular cancer	6.28e-05	0.00047	CcSEcCtD
Indomethacin—Anorexia—Epirubicin—testicular cancer	6.28e-05	0.00047	CcSEcCtD
Indomethacin—Dyspnoea—Methotrexate—testicular cancer	6.27e-05	0.00047	CcSEcCtD
Indomethacin—Somnolence—Methotrexate—testicular cancer	6.25e-05	0.000469	CcSEcCtD
Indomethacin—ABCB1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	6.23e-05	0.00211	CbGpPWpGaD
Indomethacin—Dyspepsia—Methotrexate—testicular cancer	6.19e-05	0.000464	CcSEcCtD
Indomethacin—Hypotension—Epirubicin—testicular cancer	6.15e-05	0.000461	CcSEcCtD
Indomethacin—Confusional state—Doxorubicin—testicular cancer	6.14e-05	0.00046	CcSEcCtD
Indomethacin—Decreased appetite—Methotrexate—testicular cancer	6.12e-05	0.000458	CcSEcCtD
Indomethacin—Anaphylactic shock—Doxorubicin—testicular cancer	6.09e-05	0.000456	CcSEcCtD
Indomethacin—Oedema—Doxorubicin—testicular cancer	6.09e-05	0.000456	CcSEcCtD
Indomethacin—Fatigue—Methotrexate—testicular cancer	6.07e-05	0.000455	CcSEcCtD
Indomethacin—PPARG—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	6.03e-05	0.00204	CbGpPWpGaD
Indomethacin—Pain—Methotrexate—testicular cancer	6.02e-05	0.000451	CcSEcCtD
Indomethacin—Shock—Doxorubicin—testicular cancer	5.99e-05	0.000449	CcSEcCtD
Indomethacin—Thrombocytopenia—Doxorubicin—testicular cancer	5.96e-05	0.000447	CcSEcCtD
Indomethacin—Insomnia—Epirubicin—testicular cancer	5.95e-05	0.000446	CcSEcCtD
Indomethacin—Tachycardia—Doxorubicin—testicular cancer	5.95e-05	0.000446	CcSEcCtD
Indomethacin—PLA2G2A—Metabolism—HPGDS—testicular cancer	5.91e-05	0.002	CbGpPWpGaD
Indomethacin—Paraesthesia—Epirubicin—testicular cancer	5.91e-05	0.000443	CcSEcCtD
Indomethacin—Hyperhidrosis—Doxorubicin—testicular cancer	5.89e-05	0.000441	CcSEcCtD
Indomethacin—Dyspnoea—Epirubicin—testicular cancer	5.87e-05	0.00044	CcSEcCtD
Indomethacin—Somnolence—Epirubicin—testicular cancer	5.85e-05	0.000439	CcSEcCtD
Indomethacin—PTGS2—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	5.84e-05	0.00198	CbGpPWpGaD
Indomethacin—Anorexia—Doxorubicin—testicular cancer	5.81e-05	0.000435	CcSEcCtD
Indomethacin—Feeling abnormal—Methotrexate—testicular cancer	5.8e-05	0.000434	CcSEcCtD
Indomethacin—Dyspepsia—Epirubicin—testicular cancer	5.8e-05	0.000434	CcSEcCtD
Indomethacin—CYP2C9—Biological oxidations—HPGDS—testicular cancer	5.79e-05	0.00196	CbGpPWpGaD
Indomethacin—Gastrointestinal pain—Methotrexate—testicular cancer	5.75e-05	0.000431	CcSEcCtD
Indomethacin—Decreased appetite—Epirubicin—testicular cancer	5.72e-05	0.000429	CcSEcCtD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—testicular cancer	5.69e-05	0.00193	CbGpPWpGaD
Indomethacin—Hypotension—Doxorubicin—testicular cancer	5.69e-05	0.000427	CcSEcCtD
Indomethacin—Fatigue—Epirubicin—testicular cancer	5.68e-05	0.000425	CcSEcCtD
Indomethacin—Constipation—Epirubicin—testicular cancer	5.63e-05	0.000422	CcSEcCtD
Indomethacin—Pain—Epirubicin—testicular cancer	5.63e-05	0.000422	CcSEcCtD
Indomethacin—Urticaria—Methotrexate—testicular cancer	5.59e-05	0.000419	CcSEcCtD
Indomethacin—Abdominal pain—Methotrexate—testicular cancer	5.56e-05	0.000417	CcSEcCtD
Indomethacin—Body temperature increased—Methotrexate—testicular cancer	5.56e-05	0.000417	CcSEcCtD
Indomethacin—SLCO1A2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.55e-05	0.00188	CbGpPWpGaD
Indomethacin—Insomnia—Doxorubicin—testicular cancer	5.51e-05	0.000413	CcSEcCtD
Indomethacin—Paraesthesia—Doxorubicin—testicular cancer	5.47e-05	0.00041	CcSEcCtD
Indomethacin—Dyspnoea—Doxorubicin—testicular cancer	5.43e-05	0.000407	CcSEcCtD
Indomethacin—Feeling abnormal—Epirubicin—testicular cancer	5.43e-05	0.000407	CcSEcCtD
Indomethacin—Somnolence—Doxorubicin—testicular cancer	5.42e-05	0.000406	CcSEcCtD
Indomethacin—Gastrointestinal pain—Epirubicin—testicular cancer	5.38e-05	0.000403	CcSEcCtD
Indomethacin—Dyspepsia—Doxorubicin—testicular cancer	5.36e-05	0.000402	CcSEcCtD
Indomethacin—PTGDR2—Signaling Pathways—H2AFZ—testicular cancer	5.35e-05	0.00181	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—STK11—testicular cancer	5.32e-05	0.0018	CbGpPWpGaD
Indomethacin—Decreased appetite—Doxorubicin—testicular cancer	5.3e-05	0.000397	CcSEcCtD
Indomethacin—Fatigue—Doxorubicin—testicular cancer	5.25e-05	0.000394	CcSEcCtD
Indomethacin—Urticaria—Epirubicin—testicular cancer	5.23e-05	0.000392	CcSEcCtD
Indomethacin—Pain—Doxorubicin—testicular cancer	5.21e-05	0.00039	CcSEcCtD
Indomethacin—Constipation—Doxorubicin—testicular cancer	5.21e-05	0.00039	CcSEcCtD
Indomethacin—Abdominal pain—Epirubicin—testicular cancer	5.2e-05	0.00039	CcSEcCtD
Indomethacin—Body temperature increased—Epirubicin—testicular cancer	5.2e-05	0.00039	CcSEcCtD
Indomethacin—UGT1A9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5.18e-05	0.00176	CbGpPWpGaD
Indomethacin—Hypersensitivity—Methotrexate—testicular cancer	5.18e-05	0.000388	CcSEcCtD
Indomethacin—Asthenia—Methotrexate—testicular cancer	5.05e-05	0.000378	CcSEcCtD
Indomethacin—SLC10A1—Metabolism—HPGDS—testicular cancer	5.03e-05	0.0017	CbGpPWpGaD
Indomethacin—Feeling abnormal—Doxorubicin—testicular cancer	5.02e-05	0.000376	CcSEcCtD
Indomethacin—ABCC1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	5e-05	0.00169	CbGpPWpGaD
Indomethacin—Gastrointestinal pain—Doxorubicin—testicular cancer	4.98e-05	0.000373	CcSEcCtD
Indomethacin—Pruritus—Methotrexate—testicular cancer	4.98e-05	0.000373	CcSEcCtD
Indomethacin—PTGDR2—Signaling Pathways—KITLG—testicular cancer	4.92e-05	0.00167	CbGpPWpGaD
Indomethacin—Hypersensitivity—Epirubicin—testicular cancer	4.85e-05	0.000363	CcSEcCtD
Indomethacin—Urticaria—Doxorubicin—testicular cancer	4.84e-05	0.000363	CcSEcCtD
Indomethacin—Abdominal pain—Doxorubicin—testicular cancer	4.82e-05	0.000361	CcSEcCtD
Indomethacin—Body temperature increased—Doxorubicin—testicular cancer	4.82e-05	0.000361	CcSEcCtD
Indomethacin—Diarrhoea—Methotrexate—testicular cancer	4.81e-05	0.000361	CcSEcCtD
Indomethacin—SLCO1B1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.75e-05	0.00161	CbGpPWpGaD
Indomethacin—Asthenia—Epirubicin—testicular cancer	4.72e-05	0.000354	CcSEcCtD
Indomethacin—Pruritus—Epirubicin—testicular cancer	4.66e-05	0.000349	CcSEcCtD
Indomethacin—Dizziness—Methotrexate—testicular cancer	4.65e-05	0.000349	CcSEcCtD
Indomethacin—Diarrhoea—Epirubicin—testicular cancer	4.5e-05	0.000338	CcSEcCtD
Indomethacin—Hypersensitivity—Doxorubicin—testicular cancer	4.49e-05	0.000336	CcSEcCtD
Indomethacin—Vomiting—Methotrexate—testicular cancer	4.47e-05	0.000335	CcSEcCtD
Indomethacin—Rash—Methotrexate—testicular cancer	4.44e-05	0.000332	CcSEcCtD
Indomethacin—Dermatitis—Methotrexate—testicular cancer	4.43e-05	0.000332	CcSEcCtD
Indomethacin—Headache—Methotrexate—testicular cancer	4.41e-05	0.00033	CcSEcCtD
Indomethacin—Asthenia—Doxorubicin—testicular cancer	4.37e-05	0.000328	CcSEcCtD
Indomethacin—Dizziness—Epirubicin—testicular cancer	4.35e-05	0.000326	CcSEcCtD
Indomethacin—AKR1C3—Metabolism—HPGDS—testicular cancer	4.32e-05	0.00146	CbGpPWpGaD
Indomethacin—Pruritus—Doxorubicin—testicular cancer	4.31e-05	0.000323	CcSEcCtD
Indomethacin—PLA2G2A—Metabolism—STK11—testicular cancer	4.3e-05	0.00146	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	4.23e-05	0.00143	CbGpPWpGaD
Indomethacin—Vomiting—Epirubicin—testicular cancer	4.19e-05	0.000314	CcSEcCtD
Indomethacin—Nausea—Methotrexate—testicular cancer	4.18e-05	0.000313	CcSEcCtD
Indomethacin—Diarrhoea—Doxorubicin—testicular cancer	4.17e-05	0.000312	CcSEcCtD
Indomethacin—Rash—Epirubicin—testicular cancer	4.15e-05	0.000311	CcSEcCtD
Indomethacin—Dermatitis—Epirubicin—testicular cancer	4.15e-05	0.000311	CcSEcCtD
Indomethacin—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	4.14e-05	0.0014	CbGpPWpGaD
Indomethacin—Headache—Epirubicin—testicular cancer	4.12e-05	0.000309	CcSEcCtD
Indomethacin—Dizziness—Doxorubicin—testicular cancer	4.03e-05	0.000302	CcSEcCtD
Indomethacin—Nausea—Epirubicin—testicular cancer	3.91e-05	0.000293	CcSEcCtD
Indomethacin—Vomiting—Doxorubicin—testicular cancer	3.87e-05	0.00029	CcSEcCtD
Indomethacin—Rash—Doxorubicin—testicular cancer	3.84e-05	0.000288	CcSEcCtD
Indomethacin—Dermatitis—Doxorubicin—testicular cancer	3.84e-05	0.000288	CcSEcCtD
Indomethacin—PPARA—Developmental Biology—MMP2—testicular cancer	3.83e-05	0.0013	CbGpPWpGaD
Indomethacin—Headache—Doxorubicin—testicular cancer	3.82e-05	0.000286	CcSEcCtD
Indomethacin—AKR1C3—Disease—H2AFZ—testicular cancer	3.77e-05	0.00128	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—HPGDS—testicular cancer	3.75e-05	0.00127	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—FGFR3—testicular cancer	3.66e-05	0.00124	CbGpPWpGaD
Indomethacin—SLC10A1—Metabolism—STK11—testicular cancer	3.65e-05	0.00124	CbGpPWpGaD
Indomethacin—Nausea—Doxorubicin—testicular cancer	3.62e-05	0.000271	CcSEcCtD
Indomethacin—PPARA—Gene Expression—H2AFZ—testicular cancer	3.52e-05	0.00119	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KITLG—testicular cancer	3.47e-05	0.00118	CbGpPWpGaD
Indomethacin—PTGDR2—Signaling Pathways—KIT—testicular cancer	3.36e-05	0.00114	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	3.35e-05	0.00114	CbGpPWpGaD
Indomethacin—AKR1C3—Metabolism—STK11—testicular cancer	3.14e-05	0.00106	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—HPGDS—testicular cancer	2.84e-05	0.000962	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—HPGDS—testicular cancer	2.84e-05	0.000962	CbGpPWpGaD
Indomethacin—PPARG—Developmental Biology—MMP2—testicular cancer	2.75e-05	0.00093	CbGpPWpGaD
Indomethacin—PPARA—Metabolism—STK11—testicular cancer	2.72e-05	0.000923	CbGpPWpGaD
Indomethacin—ALB—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.71e-05	0.000919	CbGpPWpGaD
Indomethacin—CXCL8—Metabolism of proteins—MMP2—testicular cancer	2.69e-05	0.000911	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—HPGDS—testicular cancer	2.69e-05	0.00091	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—H2AFZ—testicular cancer	2.64e-05	0.000895	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—STK11—testicular cancer	2.63e-05	0.00089	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—FGFR3—testicular cancer	2.58e-05	0.000874	CbGpPWpGaD
Indomethacin—PPARG—Gene Expression—H2AFZ—testicular cancer	2.52e-05	0.000855	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—HPGDS—testicular cancer	2.47e-05	0.000838	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.44e-05	0.000825	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KITLG—testicular cancer	2.43e-05	0.000823	CbGpPWpGaD
Indomethacin—AKR1C3—Disease—KIT—testicular cancer	2.37e-05	0.000802	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—HPGDS—testicular cancer	2.31e-05	0.000782	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—HPGDS—testicular cancer	2.31e-05	0.000782	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—HPGDS—testicular cancer	2.23e-05	0.000754	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism of lipids and lipoproteins—HPGDS—testicular cancer	2.22e-05	0.000752	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—HPGDS—testicular cancer	2.12e-05	0.000717	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—H2AFZ—testicular cancer	2.08e-05	0.000706	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—STK11—testicular cancer	2.07e-05	0.000702	CbGpPWpGaD
Indomethacin—UGT2B7—Metabolism—STK11—testicular cancer	2.06e-05	0.000699	CbGpPWpGaD
Indomethacin—ABCC3—Metabolism—STK11—testicular cancer	2.06e-05	0.000699	CbGpPWpGaD
Indomethacin—PPARG—Metabolism—STK11—testicular cancer	1.95e-05	0.000661	CbGpPWpGaD
Indomethacin—ABCC1—Disease—H2AFZ—testicular cancer	1.94e-05	0.000658	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KITLG—testicular cancer	1.92e-05	0.000649	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—HPGDS—testicular cancer	1.88e-05	0.000637	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—FGFR3—testicular cancer	1.81e-05	0.000612	CbGpPWpGaD
Indomethacin—SLCO1A2—Metabolism—STK11—testicular cancer	1.8e-05	0.000609	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KITLG—testicular cancer	1.79e-05	0.000605	CbGpPWpGaD
Indomethacin—UGT1A9—Metabolism—STK11—testicular cancer	1.68e-05	0.000568	CbGpPWpGaD
Indomethacin—UGT1A1—Metabolism—STK11—testicular cancer	1.68e-05	0.000568	CbGpPWpGaD
Indomethacin—AKR1C3—Signaling Pathways—KIT—testicular cancer	1.66e-05	0.000562	CbGpPWpGaD
Indomethacin—ABCC1—Metabolism—STK11—testicular cancer	1.62e-05	0.000548	CbGpPWpGaD
Indomethacin—SLCO1B1—Metabolism—STK11—testicular cancer	1.54e-05	0.000521	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—HPGDS—testicular cancer	1.49e-05	0.000506	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—FGFR3—testicular cancer	1.42e-05	0.000483	CbGpPWpGaD
Indomethacin—PTGS1—Metabolism—STK11—testicular cancer	1.37e-05	0.000463	CbGpPWpGaD
Indomethacin—ABCC1—Disease—FGFR3—testicular cancer	1.33e-05	0.00045	CbGpPWpGaD
Indomethacin—CXCL8—Signaling Pathways—KIT—testicular cancer	1.31e-05	0.000443	CbGpPWpGaD
Indomethacin—PTGS2—Disease—H2AFZ—testicular cancer	1.3e-05	0.000442	CbGpPWpGaD
Indomethacin—ABCC1—Disease—KIT—testicular cancer	1.22e-05	0.000413	CbGpPWpGaD
Indomethacin—ALB—Metabolism—HPGDS—testicular cancer	1.21e-05	0.000409	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KITLG—testicular cancer	1.2e-05	0.000406	CbGpPWpGaD
Indomethacin—PTGS2—Metabolism—STK11—testicular cancer	1.09e-05	0.000368	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—HPGDS—testicular cancer	1.09e-05	0.000368	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—HPGDS—testicular cancer	1.06e-05	0.000359	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—HPGDS—testicular cancer	9.89e-06	0.000335	CbGpPWpGaD
Indomethacin—PTGS2—Disease—FGFR3—testicular cancer	8.91e-06	0.000302	CbGpPWpGaD
Indomethacin—ALB—Metabolism—STK11—testicular cancer	8.78e-06	0.000297	CbGpPWpGaD
Indomethacin—PTGS2—Disease—KIT—testicular cancer	8.18e-06	0.000277	CbGpPWpGaD
Indomethacin—CYP2C19—Metabolism—STK11—testicular cancer	7.88e-06	0.000267	CbGpPWpGaD
Indomethacin—ABCB1—Metabolism—STK11—testicular cancer	7.69e-06	0.000261	CbGpPWpGaD
Indomethacin—CYP2C9—Metabolism—STK11—testicular cancer	7.19e-06	0.000243	CbGpPWpGaD
